About Kemio Solutions
Kemio Solutions is a company based in Bengaluru (India) founded in 2015 by Aruna Gangadharan and Narendra Kumar. It operates as a B2B. The company has 2 employees as of March 31, 2022. Kemio Solutions offers products and services including Drug Discovery Service, Drug Development Service, and Drug Manufacturing Service. Kemio Solutions operates in a competitive market with competitors including Gentronix, Tigermed, Shanghai Semero Biotechnology, Gubra and BioQual, among others.
- Headquarter Bengaluru, India
- Employees 2 as on 31 Mar, 2022
- Founders Aruna Gangadharan, Narendra Kumar
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kemio Solutions Private Limited
- Date of Incorporation 18 May, 2015
- Jurisdiction Dod Ballapur, Karnataka, India
-
Annual Revenue
$112.25 K (USD)-0.85as on Mar 31, 2022
-
Net Profit
-$357.39 (USD)94.5as on Mar 31, 2022
-
EBITDA
$47.14 K (USD)118.78as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
2
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kemio Solutions
Kemio Solutions offers a comprehensive portfolio of products and services, including Drug Discovery Service, Drug Development Service, and Drug Manufacturing Service.
Offers hit-to-lead and GMP manufacturing for clinical candidates.
Provides early-phase development and library synthesis support.
Handles custom manufacturing of NCEs and intermediates.
Funding Insights of Kemio Solutions
Detailed funding history for Kemio Solutions
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kemio Solutions
Investment portfolio details for Kemio Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kemio Solutions
Detailed financials for Kemio Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kemio Solutions Comparisons
Peer comparison for Kemio Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kemio Solutions
Kemio Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Tigermed, Shanghai Semero Biotechnology, Gubra and BioQual, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| Locked | Locked | Locked |
Drug development and preclinical services are provided by Tigermed.
|
|
| Locked | Locked | Locked |
Diversified preclinical services for brain-related disorders are provided.
|
|
| Locked | Locked | Locked |
Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided.
|
|
| Locked | Locked | Locked |
Contract research on infectious disease models is conducted.
|
|
| Locked | Locked | Locked |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
Detailed competitors of Kemio Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kemio Solutions
Complete news archive for Kemio Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kemio Solutions
Kemio Solutions was founded in 2015.
Kemio Solutions is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Narendra Kumar is the current CEO of Kemio Solutions. They have also founded this company.
As of Mar 31, 2022, the latest employee count at Kemio Solutions is 2.
Annual revenue of Kemio Solutions is $112.25K as on Mar 31, 2022.
Kemio Solutions is a contract research organization based in India that delivers integrated CRAMS services, including drug discovery, development, and manufacturing. It supports global pharmaceutical and biotech companies through expertise in chemical process research, regulatory support, and production of clinical candidates. The organization emphasizes transparency, quality, and partnership in executing pre-clinical programs, working with clients like academic institutions and startups to accelerate projects.
Kemio Solutions offers Drug Discovery Service, Drug Development Service, and Drug Manufacturing Service.